About Vaxxas Vaxxas is a biotechnology company pioneering a needle-free vaccination technology designed to enhance immune response, reduce costs, and improve accessibility. The company recently ...

Brisbane-based ObvioHealth has signed a three-year agreement with clinical-stage biotechnology company Vaxxas to support late-stage trials.

One of the most pernicious conditions that afflicts around five million people worldwide is “geographic atrophy,” or GA, an advanced form of dry age-related macular degeneration that is one of the ...